Alembic Pharmaceuticals said that it has received final approval from the US Food & Drug Administration (USFDA) for its abbreviated new drug application (ANDA) for Diltiazem Hydrochloride extended-release capsules.
| Subscribe To Our Free Newsletter |
The Most Valuable Commodity Is Information!
